Potentiating Antitumor Efficacy Through Radiation and Sustained Intratumoral Delivery of Anti-CD40 and Anti-PDL1
Hsuan‐Chen LiuDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, TexasDixita ViswanathDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, Texas; Texas A&M University, College of Medicine, Bryan, TexasFederica PesaresiDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, Texas; Department of Electronics and Telecommunications, Politecnico di Torino, Torino, ItalyYitian XuCenter for Immunotherapy Research, Houston Methodist Research Institute, Houston, Texas; ImmunoMonitoring Core, Houston Methodist Research Institute, Houston, TexasLicheng ZhangCenter for Immunotherapy Research, Houston Methodist Research Institute, Houston, Texas; ImmunoMonitoring Core, Houston Methodist Research Institute, Houston, TexasNicola Di TraniDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, Texas; University of Chinese Academy of Science (UCAS), Beijing, ChinaJesus Paez‐MayorgaDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, Texas; Tecnologico de Monterrey, School of Medicine and Health Sciences, Monterrey, NL, MexicoNathanael HernandezDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, TexasYu WangDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, TexasDonald R. ErmDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, TexasJeremy HoDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, Texas; Weill Cornell Medical College, Weill Cornell Medicine, New York, New YorkAntonia SusnjarDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, TexasXuewu LiuDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, TexasSandra DemariaWeill Cornell Medical College, Weill Cornell Medicine, New York, New YorkShu‐Hsia ChenCenter for Immunotherapy Research, Houston Methodist Research Institute, Houston, Texas; ImmunoMonitoring Core, Houston Methodist Research Institute, Houston, TexasBin S. TehWeill Cornell Medical College, Weill Cornell Medicine, New York, New York; Department of Radiation Oncology, Houston Methodist Research Institute, Houston, TexasE. Brian ButlerDepartment of Radiation Oncology, Houston Methodist Research Institute, Houston, TexasCorrine Ying Xuan ChuaDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, Texas. Electronic address: [email protected]Alessandro GrattoniDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, Texas; Department of Radiation Oncology, Houston Methodist Research Institute, Houston, Texas; Department of Surgery, Houston Methodist Research Institute, Houston, Texas. Electronic address: [email protected]
2020en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0